CIK 0001711279 · Large accelerated filer
Krystal Biotech, Inc.
Sign in to watch- Ticker
- KRYS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 821080209
- Phone
- (412) 586-5830
- Business address
- 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
- 4 Open-market sale Director sold 20,000 shares at an average $164.13 ($3,282,690)
- 8-K Event Shareholder vote results
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Planned sale President, R&D sold 50,000 shares at an average $170.95 ($8,547,719)
- 4 Planned sale President and CEO sold 50,000 shares at an average $170.95 ($8,547,719)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Chief Accounting Officer sold 5,000 shares at an average $165.88 ($829,417)
- 4 Planned sale Chief Accounting Officer sold 7,500 shares at an average $166.05 ($1,245,381)
- 4 Shares withheld for taxes President, R&D gave up 9,256 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 9,256 shares (to pay taxes)
- 4 Shares withheld for taxes President, R&D gave up 2,353 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 3,791 shares (to pay taxes)
- 4 Planned sale Chief Accounting Officer sold 8,087 shares at an average $136.91 ($1,107,180)
- 144 Insider Sale of Securities
Page 8 of 26 · 513 filings